You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/etTSqwBHkSTi/

Embed Video HTML

Request Moderation

Registered user account required

Please Login or Register to submit a moderation request.

Email Submissions

We also accept moderation reports via email. Please see the Content Moderation Policy for instructions on how to make a moderation request via email.

Add to Playlist

RECENT META-ANALYSES OF RANDOMISED TRIALS WITH IVERMECTIN NEED MORE EXPOSURE BY THE MEDIA

Watch

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 10:45 UTC on July 11th, 2021.

#covid
#ivermectin
#meta-analysis

[email protected]

Dr Deepak Natarajan

subscribers

Two recently published meta-analyses of randomised trial with ivermectin in patients with Covid 19 have shown significant reduction in mortality. Lower levels of inflammatory markers ( d Dimer, CRP and ferritin) have been associated with ivermectin …

Strangely there has hardly been any stir in the Western press; it is difficult to fathom the reasons. Hopefully the Indian press gets more excited.

The 2 trials need exposure, especially considering “breakthrough” infections despite being fully vaccinated against the Delta variant.

It is obvious that more C 19 variants shall keep popping up.

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
American Journal of Therapeutics 28, e434–e460 (2021)

Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
Published by Oxford University Press on behalf of Infectious Diseases Society of America.

LESS